Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Asthma
Interventions: Inhaler sensor, Mobile application for asthma adherence; Device · Behavioral
Lead sponsor: CoheroHealth; Industry
Eligibility: 11 Years to 19 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Health Behavior, Behavioral Activation, Sedentary Behavior
Interventions: Behavioral: Mobile Behavioral Activation App, Mobile App + Wearable Activity Sensor, Mobile App + Wearable Sensor + Secure Activity Verification Layer; Behavioral
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 227,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2099
U.S. locations: 1
States / cities: New York, New York

Conditions: Appendix Rupture, Pain, Pain, Postoperative
Interventions: VR-Biofeedback, VR-Distraction; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 8 Years to 18 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Disabilities Multiple
Interventions: ENGAGE; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dermatitis, Contact
Interventions: Organic, Unrefined Coconut Oil, Medline Remedy Phytoplex Z-Guard Skin Protectant; Other
Lead sponsor: Genesis Health System; Other
Eligibility: 5 Hours to 2 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction, Bladder Dysfunction
Interventions: DFree Non-Invasive Bladder Ultrasound, Perifit Kegel Exerciser, Exit interview; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Glioma, Glioblastoma
Interventions: Focused ultrasound (FUS); Device
Lead sponsor: InSightec; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Baltimore, Maryland • Boston, Massachusetts • Charlottesville, Virginia + 1 more

Conditions: Glomerulosclerosis, Focal
Interventions: Cyclosporin, Mycophenolate mofetil and Dexamethasone; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 2 Years to 40 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Peripheral Neuropathy, Pain, Neuropathic, Diabetes
Interventions: Moxibustion - Traditional (Active), Moxibustion - Smokeless - (Active), Placebo Moxibustion; Other
Lead sponsor: New York University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: New York, New York

Conditions: Uveitis, Macular Edema
Interventions: Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg, Intravitreal Ranibizumab 0.5 mg; Drug
Lead sponsor: JHSPH Center for Clinical Trials; Other
Eligibility: 18 Years and older
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 19
States / cities: Los Angeles, California • San Francisco, California • Miami, Florida + 13 more

Conditions: Status Epilepticus
Interventions: lorazepam or diazepam; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 3 Months to 18 Years
Enrollment: 259 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 12
States / cities: Davis, California • Aurora, Colorado • Washington D.C., District of Columbia + 9 more

Conditions: Diabetic Peripheral Neuropathic Pain
Interventions: YJ001 for Spray Use, Placebo of YJ001 for Spray Use; Drug
Lead sponsor: Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Fredericksburg, Texas

Conditions: Chronic Low Back Pain
Interventions: Biofreeze, Placebo; Drug
Lead sponsor: Sport and Spine Rehab Clinical Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Heart Failure
Interventions: Mobile Health Technology Platform, Usual care; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Skin and Fat Redundancy and Muscle Diastases
Interventions: Ultrasonic scalpel, monopolar electrosurgery generator and tip; Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Coralville, Iowa • Cincinnati, Ohio

Conditions: Kidney Stone
Interventions: iPhone Application, Android Application; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cardiac Disease
Interventions: Diagnostic Test: Limited Echocardiogram; Diagnostic Test
Lead sponsor: Sara Guttas; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 2
States / cities: Chicago, Illinois • Minneapolis, Minnesota

Conditions: Type 1 Diabetes
Interventions: Medtronic MiniMed Closed Loop (CL) System, Snacking; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 44 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pain, Postoperative, Ankle Fracture Surgery, Opioid Use Disorder, Opioid Dependence, Opioid Analgesia
Interventions: Buprenorphine Transdermal System, Placebo Patch; Drug
Lead sponsor: Jenna-Leigh Wilson; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Self-Injurious Behavior
Interventions: Noncontingent Reinforcement (NCR), Combination Treatment; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 4 Years to 25 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Postoperative Pain, Anxiety Postoperative, Opioid Use
Interventions: Virtual Realty using a Microsoft Hololens, Empatica HR wristband, and EEG, Essence Olfactory Necklace, Bedside Olfaction Device; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vascular Anomaly
Interventions: Topical Sirolimus; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 36 Months to 21 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Jacksonville, Florida • Orlando, Florida

Conditions: Smoking Cessation
Interventions: E-cigarette free access, E-cigarette/NRT/Zyban/Chantix Choice, Outcome Incentive arm, Loss framing incentive arm, Control; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 99 Years
Enrollment: 6,006 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye, Ocular Hypertension (OHT)
Interventions: Experimental: QLS-111 ophthalmic solution, (0.015%), Experimental: QLS-111 ophthalmic solution, (0.03%), Experimental: QLS-111 ophthalmic solution, (0.075%), QLS-111 ophthalmic vehicle solution; Drug · Other
Lead sponsor: Qlaris Bio, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Roswell, Georgia

Search by objective public record fields.

Assessment of a Mobile Intervention to Increase Adherence to Asthma Medication Among Adolescents

Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification

Virtual Reality for Appendectomy Pain

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population

Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)

Distal Peripheral Neuropathy in Type 2 Diabetes

Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)

MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain

Heart Failure Self-care Mobile Application to Reduce Readmissions Trial

Harmonic™ vs. Electrocautery in Abdominoplasties

Fluid Intake Application to Reduce Kidney Stone Risks

Point-of-Care Echocardiography With Assistance Technology

Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop

Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery

A Clinical Trial for Self-Injurious Behavior

Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery

Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions

Randomized Clinical Trial to Reduce Harm From Tobacco

Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients